These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 21483627)

  • 1. Therapeutic options for intermediate-advanced hepatocellular carcinoma.
    Zhang ZM; Guo JX; Zhang ZC; Jiang N; Zhang ZY; Pan LJ
    World J Gastroenterol; 2011 Apr; 17(13):1685-9. PubMed ID: 21483627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY
    Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of successful surgical resection after repeated transcatheter arterial chemoembolization for far advanced multiple hepatocellular carcinomas in both lobes associated with Vp₂ portal vein tumor thrombus].
    Maeda S; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2036-8. PubMed ID: 22202276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
    Lencioni R; Chen XP; Dagher L; Venook AP
    Oncologist; 2010; 15 Suppl 4():42-52. PubMed ID: 21115580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment modalities for hepatocellular carcinoma.
    Hung H
    Curr Cancer Drug Targets; 2005 Mar; 5(2):131-8. PubMed ID: 15810877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.
    Nakamura K; Beppu T; Hayashi H; Okabe H; Imai K; Nitta H; Chikamoto A; Ishiko T; Sasaki M; Baba H
    Int Surg; 2015 May; 100(5):908-14. PubMed ID: 26011214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Patient Outcome after Non-curative Resection for Hepatocellular Carcinoma Using Nationwide Survey Data in Japan.
    Aoki T; Kubota K; Kubo S; Eguchi S; Izumi N; Kokudo N; Sakamoto M; Shiina S; Takayama T; Nakashima O; Matsuyama Y; Murakami T; Kudo M
    World J Surg; 2021 Feb; 45(2):607-614. PubMed ID: 33104834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatocellular carcinoma: beyond international guidelines.
    Colombo M; Sangiovanni A
    Liver Int; 2015 Jan; 35 Suppl 1():129-38. PubMed ID: 25529098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.
    Peng ZW; Chen MS
    Oncology; 2013; 84 Suppl 1():40-3. PubMed ID: 23428857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.
    Song MJ
    World J Gastroenterol; 2015 Apr; 21(13):3843-9. PubMed ID: 25852268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical resection and liver transplantation for hepatocellular carcinoma.
    Akoad ME; Pomfret EA
    Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete pathological response induced by sorafenib for advanced hepatocellular carcinoma with multiple lung metastases and venous tumor thrombosis allowing for curative resection.
    Kitajima T; Hatano E; Mitsunori Y; Taura K; Fujimoto Y; Mizumoto M; Okajima H; Kaido T; Minamiguchi S; Uemoto S
    Clin J Gastroenterol; 2015 Oct; 8(5):300-5. PubMed ID: 26249525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
    Zhu J; Yin T; Xu Y; Lu XJ
    J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.
    Gish RG; Finn RS; Marrero JA
    Clin Adv Hematol Oncol; 2013 Apr; 11 Suppl 5():1-22; quiz 2 p following p22. PubMed ID: 23881427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery and transplantation for hepatocellular cancer.
    Wall WJ; Marotta PJ
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S16-22. PubMed ID: 11084080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
    Zhang GQ; Ge L; Ding W; Li HJ
    Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma.
    Ochiai T; Sonoyama T; Hironaka T; Yamagishi H
    Hepatogastroenterology; 2003; 50(51):750-5. PubMed ID: 12828078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review.
    Nishikawa H; Kita R; Kimura T; Osaki Y
    Anticancer Res; 2014 Dec; 34(12):6877-86. PubMed ID: 25503113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes.
    Chen XP; Huang ZY
    Langenbecks Arch Surg; 2005 Jun; 390(3):259-65. PubMed ID: 15875211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.